Have you tested positive, refused a test or have a violation for drugs or alcohol and since been removed from safety-sensitive duty?

A Substance Abuse Professional (SAP) will have to:

• Conduct a thorough face-to-face assessment

• Recommend a required plan of treatment and/or education

• Send a report to your employer about that recommendation

• Monitor your progress through that plan

• Conduct a face-to-face follow-up evaluation, to verify that you completed the recommendation and that it was successful

Getting back to work is as easy as 1, 2, 3.

Step 1: Call (757) 379-5278 to make an appointment

Step 2: PAY ONLINE

Step 3: Confirm Assignment in FMCSA CLEARING HOUSE

The FMCSA Drug and Alcohol Clearinghouse is a secure, online database that will give employers and other authorized users real-time information about commercial driver’s license (CDL) and commercial learner’s permit (CLP) holders’ drug and alcohol program violations. The Clearinghouse was an act of Congress directed by the Secretary of Transportation back in 2012.

The Clearinghouse will improve safety on our Nation’s roadways by giving employers access to information they need to make informed safety decisions about when current or prospective drivers with drug and alcohol violations can safely resume safety-sensitive functions after completing the required return-to-duty process. The Clearinghouse launched on January 6th, 2020 for those authorized to utilize it.

Drivers will need to be registered to view their own Clearinghouse record electronically, or to provide electronic consent for a current or prospective employer to conduct a full query (including pre-employment query) in the Clearinghouse. Failing to consent to a query or identify a qualified DOT Substance Abuse Professional (SAP) in the return-to-duty process will result in a driver being prohibited from performing safety-sensitive functions for the employer conducting the query.

If you choose to resume work, you will be required to undergo follow-up testing. The SAP is responsible for establishing a comprehensive follow-up testing plan, consisting of no fewer than six unannounced tests, to be conducted over a period of at least 12 months. The SAP reserves the right to mandate any number of tests within a span of up to 60 months. Notably, all specimen collections during these follow-up tests will be conducted under observation.